Atezolizumab and Bevacizumab in Rare Solid Tumors

Conditions:   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Mesothelial and Soft Tissue;   Malignant Neoplasms of Respiratory and Intrathoracic Organs
Interventions:   Drug: Atezolizumab;   Drug: Bevacizumab;   Behavioral: Phone Call
Sponsors:   M.D. Anderson Cancer Center;   Genentech, Inc.
Not yet recruiting - verified March 2017

http://ift.tt/2mm0qD8